Alesi Surgical, a Cardiff, Wales, UK-based company advancing novel technology to manage smoke created by surgical tools in operating theatres, raised £5M in funding.
The round was led by Mercia Ventures and including existing investors IP Group and Panakès Partners.
The company intends to use the funds to drive sales in the US market and to seek regulatory approvals for its products in Europe and Japan.
Led by CEO Dominic Griffiths, Alesi provides a system that uses electrical filtration to remove surgical smoke from the atmosphere. The latest version, Ultravision2, which is FDA approved, is a platform technology that can be integrated into surgical tools and existing theatre equipment. Its first integrated tool, for use in laparoscopic surgery, already has FDA approval and the launch of the IonPencil for routine surgery means it now offers smoke management solutions for all surgical procedures that create smoke.
The company’s first-generation Ultravision system was designed for laparoscopic surgery and has been used in over 40,000 procedures.
A spin-out from Cardiff University, Alesi is based at the Cardiff Medicentre and currently has a 15-strong team.
FinSMEs
19/09/2024